BACKGROUND: Current risk-adjusted models used to predict donor heart use and cardiac graft survival from organ donors after brain death (DBDs) do not include bedside critical care data. We sought to identify novel independent predictors of heart use and graft survival to better understand the relationship between donor management and transplantation outcomes. STUDY DESIGN: We conducted a prospective observational study of DBDs managed from 2008 to 2013 by 10 organ procurement organizations. Demographic data, critical care parameters, and treatments were recorded at 3 standardized time points during donor management. The primary outcomes measures were donor heart use and cardiac graft survival. RESULTS: From 3,433 DBDs, 1,134 hearts (33%) we...
Introduction To expand the donor pool, kidney transplants are being performed using donors who were ...
With improved immunosuppressive regimens, transplantation techniques, and postoperative care, heart ...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...
BACKGROUND: Current risk-adjusted models used to predict donor heart use and cardiac graft survival ...
Selection of heart donors is the most important stage on which the success of heart transplantation ...
Background-The transplantation of hearts from traumatically brain-injured (TBI) donors has been asso...
Despite the many years that brain-dead donors have been a source for heart transplants, some uncerta...
ObjectiveDonor cause of death may be a risk factor for early mortality after heart transplantation, ...
Shortage of organs for transplantation has led to the renewed interest in donation after circulatory...
Donation After Circulatory Death (DCD) is an alternative to Donation after Brain Death (DBD), and is...
BACKGROUND & AIMS: Cardiac arrest (CA) in deceased organ donors can potentially be associated with i...
Despite advances in mechanical circulatory devices and pharmacologic therapies, heart transplantatio...
none8noObjectives: A heart transplant (Htx) remains the gold standard treatment for patients with ad...
ObjectiveWe tested the hypothesis that duration of donor brain injury and death would have an advers...
<div><p>Background</p><p>Heart transplantation is life saving for patients with end-stage heart dise...
Introduction To expand the donor pool, kidney transplants are being performed using donors who were ...
With improved immunosuppressive regimens, transplantation techniques, and postoperative care, heart ...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...
BACKGROUND: Current risk-adjusted models used to predict donor heart use and cardiac graft survival ...
Selection of heart donors is the most important stage on which the success of heart transplantation ...
Background-The transplantation of hearts from traumatically brain-injured (TBI) donors has been asso...
Despite the many years that brain-dead donors have been a source for heart transplants, some uncerta...
ObjectiveDonor cause of death may be a risk factor for early mortality after heart transplantation, ...
Shortage of organs for transplantation has led to the renewed interest in donation after circulatory...
Donation After Circulatory Death (DCD) is an alternative to Donation after Brain Death (DBD), and is...
BACKGROUND & AIMS: Cardiac arrest (CA) in deceased organ donors can potentially be associated with i...
Despite advances in mechanical circulatory devices and pharmacologic therapies, heart transplantatio...
none8noObjectives: A heart transplant (Htx) remains the gold standard treatment for patients with ad...
ObjectiveWe tested the hypothesis that duration of donor brain injury and death would have an advers...
<div><p>Background</p><p>Heart transplantation is life saving for patients with end-stage heart dise...
Introduction To expand the donor pool, kidney transplants are being performed using donors who were ...
With improved immunosuppressive regimens, transplantation techniques, and postoperative care, heart ...
Background: Heart transplantation remains to date the only definite treatment option for end-stage h...